Pharvaris (PHVS) CEO Berndt Modig details stock, RSUs and options

Rhea-AI Filing Summary

Pharvaris N.V. director and Chief Executive Officer Berndt Modig filed an initial ownership report showing his equity position in the company. He directly holds 165,417 shares of common stock, plus additional restricted stock units that vest over time. He also has indirect ownership of 950,000 common shares through Schoodic Management B.V., an entity he controls. In addition, he holds multiple stock option awards on common shares with exercise prices ranging from $8.05 to $28.00 and expiration dates between 2031 and 2036, providing long-dated upside exposure tied to the company’s share price.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Modig Berndt

(Last) (First) (Middle)

1 CRANBERRY HILL SUITE 400

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/17/2026

3. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	165,417(1)	D
Common Stock	950,000	I	By Schoodic Management BV(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(3)	03/03/2036	Common Stock	210,000	$28	D
Stock Option (Right to Buy)	(4)	03/12/2035	Common Stock	180,000	$16.05	D
Stock Option (Right to Buy)	(5)	04/11/2034	Common Stock	150,000	$22.31	D
Stock Option (Right to Buy)	(6)	04/06/2033	Common Stock	170,000	$8.05	D
Stock Option (Right to Buy)	(7)	04/01/2032	Common Stock	140,000	$18.14	D
Stock Option (Right to Buy)	(8)	02/05/2031	Common Stock	250,000	$20	D

Explanation of Responses:

1. Includes restricted stock units previously granted under the Company's equity plan that remain outstanding as of March 18, 2026. The awards settle in shares of common stock and are reported in Table I as non-derivative securities. Vesting occurs as follows: -70,000 RSUs from an award granted March 3, 2026 of which 25% will vest March 3, 2027 with the remainder vesting monthly thereafter; -45,000 RSUs from an award granted March 12, 2025 of which 25% vested March 12, 2026 with the remainder vesting monthly thereafter; -26,042 RSUs from an award granted April 11, 2024 of which 25% vested April 11, 2025 with the remainder vesting monthly thereafter.

2. Schoodic Management B.V., an entity controlled by Mr. Modig

3. 25% of the option will vest on March 3, 2027 with the remaining shares vesting in 1/48 monthly installments thereafter.

4. 25% of the option vested on March 12, 2026 with the remaining shares vesting in 1/48 monthly installments thereafter.

5. 25% of the option vested on April 11, 2025 with the remaining shares vesting in 1/48 monthly installments thereafter.

6. 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.

7. 25% of the option vested on April 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter.

8. 25% of the option vested on February 2, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.

	/s/ Marnus Nel, Attorney-in-Fact for Berndt Modig	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Berndt Modig’s Form 3 filing for Pharvaris (PHVS) show?

The filing shows Berndt Modig’s initial ownership in Pharvaris. He reports direct and indirect common stock holdings plus several long-term stock option grants, outlining his equity-based alignment with the company’s future performance.

How many Pharvaris (PHVS) shares does Berndt Modig hold directly and indirectly?

Berndt Modig directly holds 165,417 Pharvaris common shares. He also has indirect ownership of 950,000 additional common shares through Schoodic Management B.V., an entity he controls, indicating substantial overall exposure to the company’s equity.

What stock options does the Pharvaris (PHVS) CEO report on his Form 3?

The CEO reports several stock option awards on Pharvaris common shares with exercise prices between $8.05 and $28.00 and expiration dates from 2031 to 2036, giving him long-term participation in potential share price appreciation.

Does the Pharvaris (PHVS) Form 3 show any recent insider buying or selling?

The Form 3 is an initial ownership statement and does not show new purchases or sales. It lists Modig’s existing common stock, restricted stock units, and stock option positions as of the reporting date.

How are Schoodic Management B.V. holdings treated in the Pharvaris (PHVS) Form 3?

The filing reports 950,000 Pharvaris common shares held indirectly through Schoodic Management B.V. A footnote explains this entity is controlled by Berndt Modig, so those shares are attributed to him as indirect ownership.

What restricted stock units (RSUs) are outstanding for the Pharvaris (PHVS) CEO?

The filing notes multiple RSU awards outstanding as of March 18, 2026, including tranches granted in 2024, 2025, and 2026. Each grant vests 25% on a specified date, with the remaining units vesting in equal monthly installments thereafter.